Clinical Microbiology And Infection For Publication
This article is protected by copyright. All rights reserved. (Source: Clinical Microbiology and Infection)
Source: Clinical Microbiology and Infection - October 1, 2014 Category: Microbiology Authors: Valentina D. Mangano, David Modiano Tags: Invited Review Source Type: research

Fecal microbiota transplantation: from practices to legislation before considering industrialization
This article is protected by copyright. All rights reserved. (Source: Clinical Microbiology and Infection)
Source: Clinical Microbiology and Infection - October 1, 2014 Category: Microbiology Authors: Jean‐Christophe Lagier Tags: Invited Review Source Type: research

Practical Implementation Of Fecal Transplantation
This article is protected by copyright. All rights reserved. (Source: Clinical Microbiology and Infection)
Source: Clinical Microbiology and Infection - October 1, 2014 Category: Microbiology Authors: N Kapel, M Thomas, O Corcos, C Mayeur, L Barbot‐Trystram, Y Bouhnik, F Joly Tags: Invited Review Source Type: research

Hepatitis C virus and interferon type III (interferon lambda 3/interleukin 28B and interferon lambda 4): genetic basis of susceptibility to infection and response to antiviral treatment
This article is protected by copyright. All rights reserved. (Source: Clinical Microbiology and Infection)
Source: Clinical Microbiology and Infection - October 1, 2014 Category: Microbiology Authors: E. Riva, C. Scagnolari, O. Turriziani, G. Antonelli Tags: Invited Review Source Type: research

Economic burden of antibiotic resistance: how much do we really know?
This article is protected by copyright. All rights reserved. (Source: Clinical Microbiology and Infection)
Source: Clinical Microbiology and Infection - October 1, 2014 Category: Microbiology Authors: Sumanth Gandra, Devra Barter, Ramanan Laxminarayan Tags: Invited Review Source Type: research

The potential beneficial role of fecal microbiota transplantation in diseases other than Clostridium difficile infection
This article is protected by copyright. All rights reserved. (Source: Clinical Microbiology and Infection)
Source: Clinical Microbiology and Infection - October 1, 2014 Category: Microbiology Authors: R. Singh, M. Nieuwdorp, I. J. M. ten Berge, F. J. Bemelman, S. E. Geerlings Tags: Invited Review Source Type: research

Fecal microbiota transplantation – the Austrian approach
This article is protected by copyright. All rights reserved. (Source: Clinical Microbiology and Infection)
Source: Clinical Microbiology and Infection - October 1, 2014 Category: Microbiology Authors: Patrizia K. Kump, Robert Krause, Franz Allerberger, Christoph Högenauer Tags: Invited Review Source Type: research

Epstein‐Barr virus‐related post‐transplant lymphoproliferative disorder in solid organ transplant recipients
Abstract Epstein‐Barr virus (EBV) contributes to the pathogenesis of post‐transplant lymphoproliferative disease (PTLD) in more than 70% of cases. EBV DNAemia surveillance has been reported to assist in the prevention and treatment of PTLD in hematopoietic stem‐cell transplantation (HSCT) recipients. Derived from experience in HSCT and taking into account that PCR‐based EBV monitoring techniques are currently available in most solid organ transplant (SOT) centres, there is a great interest in EBV surveillance and prevention of PTLD in SOT recipients. In the present document we have tried to address from a practical...
Source: Clinical Microbiology and Infection - September 9, 2014 Category: Microbiology Authors: R. San‐Juan, P. Comoli, S. Caillard, B. Moulin, H. H. Hirsch, P. Meylan, Tags: Review Source Type: research

Influenza and other respiratory virus infections in solid organ transplant recipients
This article reviews the clinical manifestations of CARVs infections and summarizes the evidence‐based recommendations on the preventive and therapeutic strategies to decrease the burden of these viral infections in SOT recipients. (Source: Clinical Microbiology and Infection)
Source: Clinical Microbiology and Infection - September 9, 2014 Category: Microbiology Authors: O. Manuel, F. López‐Medrano, L. Kaiser, T. Welte, J. Carratalà, E. Cordero, H. H. Hirsch, Tags: Review Source Type: research

Multidrug‐resistant bacteria in solid organ transplant recipients
Abstract Bacteria are the leading cause of infections after solid organ transplantation. In recent years, a progressive growth in the incidence of multidrug‐resistant (MDR) and extensively‐drug‐reistant (XDR) strains has been observed. While methicillin‐resistant Staphylococcus aureus (MRSA) infection is declining in non‐transplant and SOT patients worldwide, vancomycin‐resistant enterococci, MDR/XDR Enterobacteriaceae and MDR/XDR non‐fermenters are progressively growing as a cause of infection in solid organ transplant (SOT) patients and represent a global threat. Some SOT patients develop recurrent infectio...
Source: Clinical Microbiology and Infection - September 9, 2014 Category: Microbiology Authors: C. Cervera, C. Delden, J. Gavaldà, T. Welte, M. Akova, J. Carratalà, Tags: Review Source Type: research

Invasive fungal infections in solid organ transplant recipients
Abstract Solid organ transplant (SOT) recipients have a significant risk of invasive fungal diseases (IFD) caused mainly by Candida spp. and Aspergillus spp. Candida spp. is the most frequent agent of IFD in the transplant recipient. The absence of clinical trials and the epidemiological differences in IFD in different transplant programmes mean that there are no definitive recommendations for the diagnosis, treatment and prevention of IFD in SOT, so most of the evidence must be based on clinical experience. (Source: Clinical Microbiology and Infection)
Source: Clinical Microbiology and Infection - September 9, 2014 Category: Microbiology Authors: J. Gavaldà, Y. Meije, J. Fortún, E. Roilides, F. Saliba, O. Lortholary, P. Muñoz, P. Grossi, M. Cuenca‐Estrella, Tags: Review Source Type: research

Cytomegalovirus infection in solid organ transplant recipients
Abstract Cytomegalovirus (CMV) is the most frequent infectious complication following solid organ transplantation (SOT). The virus, is responsible for both direct (viral syndrome, hepatitis, pneumonitis, colitis, etc.) and indirect effects (rejection, infections by other microorganisms and graft dysfunction). In this evidence‐based guideline we deal with the most important aspects of CMV infection in SOT recipients, including pre‐ and post‐transplant diagnosis assessment and risk factors, with special emphasis on the prevention and treatment of this viral infection. Overall, adequate management of CMV infection is a ...
Source: Clinical Microbiology and Infection - September 9, 2014 Category: Microbiology Authors: C. Lumbreras, O. Manuel, O. Len, I. J. M. ten Berge, D. Sgarabotto, H. H. Hirsch, Tags: Review Source Type: research

A special issue on infections in solid organ transplant recipients
(Source: Clinical Microbiology and Infection)
Source: Clinical Microbiology and Infection - September 9, 2014 Category: Microbiology Authors: J. Gavaldà, J. M. Aguado, O. Manuel, P. Grossi, H. H. Hirsch, Tags: Editorial Source Type: research

In vitro evaluation of a new drug combination against clinical isolates belonging to the Mycobacterium abscessus complex
Clinical Microbiology and Infection,Volume 20, Issue 12, Page O1124-O1127, December 2014. (Source: Clinical Microbiology and Infection)
Source: Clinical Microbiology and Infection - September 3, 2014 Category: Microbiology Source Type: research

---
Clinical Microbiology and Infection,Volume 20, Issue 12, Page O1124-O1127, December 2014. (Source: Clinical Microbiology and Infection)
Source: Clinical Microbiology and Infection - September 3, 2014 Category: Microbiology Source Type: research